Expert NetworkExpert InterviewLLY

Slingshot members are talking to an expert! The topic is:

Evaluating Eli Lilly's Retatrutide's (once-weekly triple hormone receptor agonist) Phase 3 Clinical Data for Obesity Management

Executed on:Mar 30, 2026 1:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Arkansas Medical Center
  • Director of the diabetes program at UAMS Health
  • Manages about 600 patients with type 2 diabetes/obesity and 200 patients on insulin pumps
  • Clinical and research interests include type 1 diabetes, type 2 diabetes, Diabetes management with exercise, insulin pumps, closed-look insulin pump systems, and continuous glucose monitoring systems

Interview Goal

This call will focus on the landscape of obesity and the potential of Eli Lilly's triple agonist, Retatrutide.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.